# OnCo record rock425 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/rock425/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "rock425" ;
  schema:name "Rock425"@en ;
  schema:alternateName "CCR4-IL2 IT"@en, "CCR4-IL2 bispecific immunotoxin"@en ;
  schema:description "Rock425 is an experimental immunotoxin from Rock Immune that carries a disabled diphtheria toxin to malignant T cells. It is being developed for cutaneous T-cell lymphoma and has not yet been tested in people."@en ;
  schema:url <https://onco.cc/drugs/rock425/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://rockimmune.com/> ;
  onco:status "preclinical" ;
  onco:tag "pipeline" ;
  onco:modality "Recombinant immunotoxin (bispecific fusion protein)" ;
  onco:targets <https://onco.cc/targets/ccr4/> ;
  onco:companies <https://onco.cc/companies/rock-immune/> .